Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions
Sponsor
Roxane Laboratories (Industry)
Overall Status
Completed
CT.gov ID
NCT00601328
Collaborator
(none)
36
1
1
35.3
Study Details
Study Description
Brief Summary
The objective of this study was to assess the bioequivalence of Roxane Laboratories' Calcitriol capsules, 0.25 mcg, to ROCALTROL® capsules, 0.25 mcg (Roche) using a single-dose, 2-treatment, 2-period, crossover design, under fasting conditions
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
36 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions
Study Start Date
:
Jul 1, 2003
Actual Primary Completion Date
:
Aug 1, 2003
Actual Study Completion Date
:
Aug 1, 2003
Outcome Measures
Primary Outcome Measures
- Bioequivalence [Baseline, Two period, Fourteen day washout]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
Exclusion Criteria:
-
Positive test for HIV, Hepatitis B, or Hepatitis C.
-
Treatment with known enzyme altering drugs.
-
History of allergic or adverse response to Calcitriol or any comparable or similar product.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Bio-Kinetic Clinical Applications, Inc. | Springfield | Missouri | United States | 65801 |
Sponsors and Collaborators
- Roxane Laboratories
Investigators
- Principal Investigator: Dennis Morrison, DO, Bio-Kinetic Clinical Applications, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00601328
Other Study ID Numbers:
- CALC-07
First Posted:
Jan 28, 2008
Last Update Posted:
Jan 23, 2018
Last Verified:
Jan 1, 2018
Additional relevant MeSH terms: